We are live on ! Find out more
New York State Common Retirement Fund

New York State Common Retirement Fund Portfolio holdings

AUM $79.3B
1-Year Est. Return 43.63%
This Fund
S&P 500
This Quarter Est. Return
+9.95%
1 Year Est. Return
+43.63%
3 Year Est. Return
+132.82%
5 Year Est. Return
+173.87%
10 Year Est. Return
+697.67%
AUM
$84.1B
AUM Growth
+$5.09B
Cap. Flow
-$1.63B
Cap. Flow %
-1.94%
Top 10 Hldgs %
18.93%
Holding
3,277
New
52
Increased
520
Reduced
1,986
Closed
73

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$159M
2
STI
SunTrust Banks, Inc.
STI
+$56.2M
3
AAPL icon
Apple
AAPL
+$55.2M
4
DE icon
Deere & Co
DE
+$54.1M
5
JPM icon
JPMorgan Chase
JPM
+$48.2M

Sector Composition

Rank Sector Weight
1 Technology 21.32%
2 Financials 15.73%
3 Healthcare 14.42%
4 Consumer Discretionary 10.02%
5 Communication Services 9.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DYAI icon
3026
Dyadic International
DYAI
$36.4M
$68K ﹤0.01%
+13,100
New +$78.5K
LCUT icon
3027
Lifetime Brands
LCUT
$211M
$68K ﹤0.01%
9,800
CCO icon
3028
Clear Channel Outdoor Holdings
CCO
$1.23B
$67K ﹤0.01%
23,300
GAIA icon
3029
Gaia
GAIA
$48.4M
$67K ﹤0.01%
8,400
MBIO icon
3030
Mustang Bio
MBIO
$4.55M
$67K ﹤0.01%
22
MCRB icon
3031
Seres Therapeutics
MCRB
$48.9M
$67K ﹤0.01%
965
MRSN
3032
DELISTED
Mersana Therapeutics
MRSN
$67K ﹤0.01%
468
TZOO icon
3033
Travelzoo
TZOO
$75.4M
$66K ﹤0.01%
6,200
PMBC
3034
DELISTED
Pacific Mercantile Bancorp
PMBC
$66K ﹤0.01%
8,148
ABEO icon
3035
Abeona Therapeutics
ABEO
$413M
$65K ﹤0.01%
800
MEC icon
3036
Mayville Engineering Co
MEC
$617M
$65K ﹤0.01%
6,900
TPST icon
3037
Tempest Therapeutics
TPST
$14.6M
$65K ﹤0.01%
49
ESTE
3038
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
$65K ﹤0.01%
10,219
-7,881
-44% -$37.1K
FNCB
3039
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
$63K ﹤0.01%
7,490
INDT
3040
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
$63K ﹤0.01%
1,600
LCTX icon
3041
Lineage Cell Therapeutics
LCTX
$278M
$62K ﹤0.01%
69,500
WOW
3042
DELISTED
WideOpenWest
WOW
$61K ﹤0.01%
8,200
-15,300
-65% -$96.9K
TCS
3043
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$61K ﹤0.01%
960
EVC icon
3044
Entravision Communication
EVC
$1.1B
$60K ﹤0.01%
23,000
-35,300
-61% -$96.4K
SENS icon
3045
Senseonics Holdings Inc
SENS
$366M
$60K ﹤0.01%
3,275
CHGA
3046
Change Agents Corporation Common Stock
CHGA
$2.55M
$58K ﹤0.01%
199
PRPL icon
3047
Purple Innovation
PRPL
$41.7M
$57K ﹤0.01%
264
STIM icon
3048
Neuronetics
STIM
$166M
$57K ﹤0.01%
12,800
MRNS
3049
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$57K ﹤0.01%
6,550
YGYI
3050
DELISTED
Youngevity International, Inc Common Stock
YGYI
$57K ﹤0.01%
17,500

Similar funds

New York State Common Retirement Fund's Q4 2019 Portfolio in Review

As of Q4 2019, New York State Common Retirement Fund held 3,277 positions worth $84.1B, up 6.4% from $79B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 3.8%. New York State Common Retirement Fund opened 52 new positions and exited 73, leaving the 3,277-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • New York State Common Retirement Fund's largest Q4 2019 buy was Canadian National Railway: 160,800 shares worth $14.5M.
  • New York State Common Retirement Fund added most to Bristol-Myers Squibb in Q4 2019, an estimated $86.8M increase.
  • New York State Common Retirement Fund's biggest Q4 2019 reduction was Apple, cutting an estimated $55.2M.
  • New York State Common Retirement Fund fully exited Celgene Corp in Q4 2019, selling an estimated $159M.
  • New York State Common Retirement Fund's ten largest holdings make up 19% of its $84.1B portfolio in Q4 2019.
  • New York State Common Retirement Fund opened 52 new positions and closed 73 in Q4 2019.
  • New York State Common Retirement Fund's portfolio value rose 6.4% quarter-over-quarter to $84.1B.

Based on New York State Common Retirement Fund's 13F filing for Q4 2019, filed 5 Feb 2020.